Intraoperative Imaging Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Products (Mobile C Arm, Ultrasound, CT ); By Application ; By Region

Global intraoperative imaging market is flourishing due to the increasing prevalence of chronic diseases, advancements in imaging technology, a growing focus on minimally invasive surgeries, and innovations driven by modern technologies such as intraoperative MRI and optical coherence tomography.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global intraoperative imaging market size at USD 238.0 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global intraoperative imaging market size to grow at a CAGR of 13.5% reaching a value of USD 577.47 by 2029. The increasing demand for cost-effective healthcare solutions and the growing trend toward outpatient surgeries are also driving the demand for intraoperative imaging. The intraoperative imaging technology can help in reducing the length of hospital stays and minimize the need for repeat surgeries, thereby reducing overall healthcare costs. Overall, the rising demand for intraoperative imaging can be attributed to its ability to improve surgical outcomes, enhance patient safety, and reduce healthcare costs, making it an increasingly attractive option for healthcare providers and patients alike. Furthermore, the number of patients receiving treatment in hospitals for neurological illnesses like epilepsy and brain tumors is on the rise. As per the WHO, epilepsy affects over 50 million individuals globally and accounts for a considerable amount of the global disease burden. The proportion of the general population with active epilepsy is estimated to be between 4 and 10 per 1000 persons. Thus, the increasing prevalence of chronic disorders and the adoption of technically advanced imaging systems are expected to boost this segment's growth during the forecast period.

Opportunity: New Product Development and High Growth Opportunities in Emerging Economies

Developing economies including India, Brazil, South Korea, Turkey, Russia, and South Africa provide significant development potential for intraoperative imaging market participants. Although cost is an issue in these developing countries, their large population bases-particularly in India and China-indicate a long-term market for intraoperative imaging devices. The increased frequency of chronic diseases such as cancer, stroke, nephrology, neurological surgery, and cardiovascular disorders in these countries, as well as the higher death rates, highlight the need of early identification. GLOBOCAN 2018 statistics, for example, suggested that about half of the worldwide cancer population resided in developing nations. Regulatory policies in Asia-Pacific countries are more adaptable and business-friendly than in Western countries. Increased competition in developed countries is projected to push makers of intraoperative imaging systems to focus on emerging markets.

Challenges: Cuts in Healthcare Providers' Budget

In response to increased government pressure to cut healthcare costs, a number of healthcare providers have partnered with group buying organizations (GPOs), integrated health networks (IHNS), and integrated delivery networks (IDNS). These associations pool their members' purchases and negotiate a competitive price with medical equipment suppliers and manufacturers. For mass purchasing of intraoperative imaging devices, GPOs, IHNS, and IDNS bargain hard. The growing cost of prescription medications, combined with a steep decrease in anticipated budget allocations for health and human services in the United States for 2019, have resulted in major cuts to hospital budgets. According to an American Hospital Association analysis, federal hospital payment cuts totaling USD 218 billion by 2028, requiring hospitals to devote less resources yearly.

Segmental Information

Global Intraoperative Imaging Market - By End User:

Based on end user, the global intraoperative imaging market is segmented into hospitals & diagnostic centers, ambulatory surgical centers & clinics, and research laboratories & academic institutes. End users in the intraoperative imaging market were dominated by hospitals and diagnostic centers. Hospitals frequently undertake a wide range of surgical operations, the majority of which are conducted in hospital inpatient settings. The increasing number of minimally invasive operations and electro surgery treatments done in hospitals, as well as the introduction of robotic surgical, are driving growth in this market. Because of their greater purchasing power and higher volume of procedures conducted, hospitals are more likely to use intraoperative imaging equipment. The increased number of orthopedic surgeries conducted in hospitals has resulted from the rising number of vehicle accidents, fall-related injuries, and sports injuries. The increased occurrence of diseases needing surgical treatment promotes the utilization by increasing the procedure volume.

Global Intraoperative Imaging Market - By Region:

Due to the presence of a large number of market players in the region, North America held the highest market share in 2022, and their consistent efforts in developing new products, investing in acquisitions, and R&D activities to support easy operations and ensure the availability of authentic medical-grade imaging systems are expected to drive the market growth. For example, Activ Surgical, a digital surgery pioneer based in the United States, announced FDA clearance of its ActivSight Intraoperative Imaging Module for improved surgical visualization in April 2021. This imaging module provides real-time intraoperative visual data and imaging to surgeons, resulting in improved patient outcomes and operating room safety.

Impact of COVID-19 on the Global Intraoperative Imaging Market

The COVID-19 pandemic had an uneven influence on the intraoperative imaging market. While demand for imaging technologies remains high, the pandemic caused supply chain disruptions, reduced patient volumes, and financial constraints, all of which hampered market growth. Because of the rising number of COVID-19 cases globally, the pandemic spurred the demand for imaging technology in the healthcare business. Intraoperative imaging technologies are being utilized to diagnose and monitor the evolution of COVID-19 patients. Furthermore, as hospitals and healthcare facilities are converted to COVID-19 treatment, the demand for portable and mobile imaging devices has grown.

Competitive Landscape:

Key players in the global intraoperative imaging market include: General Electric Company, Siemens Healthineers AG, Ziehm Imaging GmbH, Medtronic, Koninklijke Philips NV, Canon Healthcare, Stryker, Brainlab AG, IMRIS, Shimadzu Corporation, Shenzhen Anke High-tech Co., FUJIFILM Holdings, Carl Zeiss Meditec AG, Mindray Ltd, Carestream Health, Analogic Corporation, Allengers Medical Systems Ltd, Esaote SpA, and Neurologica Corporation.

The report's in-depth analysis provides information about growth potential, upcoming trends, and the Global Intraoperative Imaging Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the global Intraoperative Imaging Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

Product Code: BWC23462

1. Research Framework

1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

2. Executive Summary

3. Global Intraoperative Imaging Market Insights

3.1. Industry Value Chain Analysis
3.2. DROC Analysis
- 3.2.1. Growth Drivers
  - 3.2.1.1. Technological Advancements in Intraoperative Imaging Modalities
  - 3.2.1.2. Increase in R&D activities in medical devices
  - 3.2.1.3. Increasing number of surgical procedures
- 3.2.2. Restraints
  - 3.2.2.1. High Cost of Intraoperative imaging systems
  - 3.2.2.2. Limited availability of skilled professionals
- 3.2.3. Opportunity
  - 3.2.3.1. High Growth Opportunities in Emerging Countries
  - 3.2.3.2. Development of low-cost imaging systems
- 3.2.4. Challenges
  - 3.2.4.1. Higher Budgets of High School
  - 3.2.4.2. Competition from alternative imaging technologies
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry

4. Global Intraoperative Imaging Market Overview

4.1. Market Size & Forecast by Value, 2019-2029
- 4.1.1. By Value (USD Billion)
4.2. Market Share & Forecast
- 4.2.1. By Product
  - 4.2.1.1. Mobile C Arm
  - 4.2.1.2. Ultrasound
  - 4.2.1.2.1. Laparoscopic probes
  - 4.2.1.2.2. Drop-in-probes
  - 4.2.1.2.3. Other devices
  - 4.2.1.3. CT
  - 4.2.1.4. MRI
  - 4.2.1.5. X rays
  - 4.2.1.6. Intraoperative Optical Imaging
- 4.2.2. By Application
  - 4.2.2.1. Neurosurgery
  - 4.2.2.2. Orthopaedic & Trauma Surgery
  - 4.2.2.3. Spine Surgery
  - 4.2.2.4. Cardiovascular Surgery
  - 4.2.2.5. ENT Surgery
  - 4.2.2.6. Oncology
  - 4.2.2.7. Emergency & Trauma Surgery
  - 4.2.2.8. Others
- 4.2.3. By Region
  - 4.2.3.1. North America
  - 4.2.3.2. Europe
  - 4.2.3.3. Asia Pacific
  - 4.2.3.4. Latin America
  - 4.2.3.5. Middle East and Africa

5. North America Intraoperative Imaging Market

5.1. Market Size & Forecast by Value, 2019-2029
- 5.1.1. By Value (USD Billion)
5.2. Market Share & Forecast
- 5.2.1. By Product
- 5.2.2. By Application
- 5.2.3. By Country
  - 5.2.3.1. United States
  - 5.2.3.1.1. By Product
  - 5.2.3.1.2. By Application
  - 5.2.3.2. Canada
  - 5.2.3.2.1. By Product
  - 5.2.3.2.2. By Application

6. Europe Intraoperative Imaging Market

6.1. Market Size & Forecast by Value, 2019-2029
- 6.1.1. By Value (USD Billion)
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Application
- 6.2.3. By Country
  - 6.2.3.1. Germany
  - 6.2.3.1.1. By Product
  - 6.2.3.1.2. By Application
  - 6.2.3.2. United Kingdom
  - 6.2.3.2.1. By Product
  - 6.2.3.2.2. By Application
  - 6.2.3.3. Italy
  - 6.2.3.3.1. By Product
  - 6.2.3.3.2. By Application
  - 6.2.3.4. France
  - 6.2.3.4.1. By Product
  - 6.2.3.4.2. By Application
  - 6.2.3.5. Spain
  - 6.2.3.5.1. By Product
  - 6.2.3.5.2. By Application
  - 6.2.3.6. Belgium
  - 6.2.3.6.1. By Product
  - 6.2.3.6.2. By Application
  - 6.2.3.7. Russia
  - 6.2.3.7.1. By Product
  - 6.2.3.7.2. By Application
  - 6.2.3.8. The Netherlands
  - 6.2.3.8.1. By Product
  - 6.2.3.8.2. By Application
  - 6.2.3.9. Rest of Europe
  - 6.2.3.9.1. By Product
  - 6.2.3.9.2. By Application

7. Asia-Pacific Intraoperative Imaging Market

7.1. Market Size & Forecast by Value, 2019-2029
- 7.1.1. By Value (USD Billion)
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Application
- 7.2.3. By Country
  - 7.2.3.1. China
  - 7.2.3.1.1. By Product
  - 7.2.3.1.2. By Application
  - 7.2.3.2. India
  - 7.2.3.2.1. By Product
  - 7.2.3.2.2. By Application
  - 7.2.3.3. Japan
  - 7.2.3.3.1. By Product
  - 7.2.3.3.2. By Application
  - 7.2.3.4. South Korea
  - 7.2.3.4.1. By Product
  - 7.2.3.4.2. By Application
  - 7.2.3.5. Australia & New Zealand
  - 7.2.3.5.1. By Product
  - 7.2.3.5.2. By Application
  - 7.2.3.6. Indonesia
  - 7.2.3.6.1. By Product
  - 7.2.3.6.2. By Application
  - 7.2.3.7. Malaysia
  - 7.2.3.7.1. By Product
  - 7.2.3.7.2. By Application
  - 7.2.3.8. Singapore
  - 7.2.3.8.1. By Product
  - 7.2.3.8.2. By Application
  - 7.2.3.9. Vietnam
  - 7.2.3.9.1. By Product
  - 7.2.3.9.2. By Application
  - 7.2.3.10. Rest of APAC
  - 7.2.3.10.1. By Product
  - 7.2.3.10.2. By Application

8. Latin America Intraoperative Imaging Market

8.1. Market Size & Forecast by Value, 2019-2029
- 8.1.1. By Value (USD Billion)
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Application
- 8.2.3. By Country
  - 8.2.3.1. Brazil
  - 8.2.3.1.1. By Product
  - 8.2.3.1.2. By Application
  - 8.2.3.2. Argentina
  - 8.2.3.2.1. By Product
  - 8.2.3.2.2. By Application
  - 8.2.3.3. Peru
  - 8.2.3.3.1. By Product
  - 8.2.3.3.2. By Application
  - 8.2.3.4. Rest of LATAM
  - 8.2.3.4.1. By Product
  - 8.2.3.4.2. By Application

9. Middle East & Africa Intraoperative Imaging Market

9.1. Market Size & Forecast by Value, 2019-2029
- 9.1.1. By Value (USD Billion)
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Application
- 9.2.3. By Country
  - 9.2.3.1. Saudi Arabia
  - 9.2.3.1.1. By Product
  - 9.2.3.1.2. By Application
  - 9.2.3.2. UAE
  - 9.2.3.2.1. By Product
  - 9.2.3.2.2. By Application
  - 9.2.3.3. Qatar
  - 9.2.3.3.1. By Product
  - 9.2.3.3.2. By Application
  - 9.2.3.4. Kuwait
  - 9.2.3.4.1. By Product
  - 9.2.3.4.2. By Application
  - 9.2.3.5. South Africa
  - 9.2.3.5.1. By Product
  - 9.2.3.5.2. By Application
  - 9.2.3.6. Nigeria
  - 9.2.3.6.1. By Product
  - 9.2.3.6.2. By Application
  - 9.2.3.7. Algeria
  - 9.2.3.7.1. By Product
  - 9.2.3.7.2. By Application
  - 9.2.3.8. Rest of MEA
  - 9.2.3.8.1. By Product
  - 9.2.3.8.2. By Application

10. Competitive Landscape

10.1. List of Key Players and Their Offerings
10.2. Global Intraoperative Imaging Company Market Share Analysis, 2021
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Intraoperative Imaging Market

12. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)

12.1. General Electric Company
12.2. Siemens Healthineers AG
12.3. Ziehm Imaging GmbH
12.4. Medtronic
12.5. Koninklijke Philips NV
12.6. Canon Healthcare
12.7. Stryker
12.8. Brainlab AG
12.9. IMRIS
12.10. Shimadzu Corporation
12.11. Shenzhen Anke High-tech Co.
12.12. FUJIFILM Holdings
12.13. Carl Zeiss Meditec AG
12.14. Mindray Ltd
12.15. Carestream Health
12.16. Analogic Corporation
12.17. Allengers Medical Systems Ltd
12.18. Esaote SpA
12.19. Neurologica Corporation
12.20. Other Prominent Companies

13. Key Strategic Recommendations

14. Research Methodology

14.1. Qualitative Research
- 14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
- 14.3.1. Secondary Research
- 14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumption & Limitation

*Financial information in case of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable